Severe Venoocclusive Disease after Liver Transplantation Treated with Transjugular Intrahepatic Portosystemic Shunt
- 15 July 2006
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 82 (1), 132-135
- https://doi.org/10.1097/01.tp.0000225799.76828.ce
Abstract
Venoocclusive disease (VOD) is due to hepatic sinusoidal lining injury leading to portal hypertension; its incidence after liver transplantation is about 2%. When severe, it does not respond to medical therapy and has a high mortality; retransplantation is the only therapeutic option. However, there are no detailed data regarding the use of transjugular intrahepatic portosystemic shunt for VOD after liver transplantation. We describe two patients who developed severe VOD after liver transplantation, failed defibrotide therapy, and were treated by transjugular intrahepatic portosystemic shunt (TIPS). The portal hypertension resolved completely and one had full histological recovery. We believe that TIPS should be attempted as it may resolve progressive portal hypertension and the hepatic congestion, while allowing the clinician time for listing for further liver transplantation if the patient fails to respond.Keywords
This publication has 14 references indexed in Scilit:
- Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatmentCurrent Opinion in Hematology, 2003
- Veno-occlusive disease of the liver in renal transplant patientsNephrology Dialysis Transplantation, 2003
- Veno-occlusive disease: cytokines, genetics, and haemostasisBlood Reviews, 2003
- Toxic Injury to Hepatic Sinusoids: Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease)Seminars in Liver Disease, 2002
- DEFIBROTIDE FOR THE TREATMENT OF VENO-OCCLUSIVE DISEASE AFTER LIVER TRANSPLANTATIONTransplantation, 2001
- The hepatologist in the haematologists' campBritish Journal of Haematology, 2001
- Transjugular intrahepatic portosystemic shunt (TIPS) for severe veno-occlusive disease of the liver following bone marrow transplantationBone Marrow Transplantation, 2000
- “Silent” presentation of veno-occlusive disease after liver transplantation as part of the process of cellular rejection with endothelial predilectionHepatology, 1999
- Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: Incidence, risk factors, and outcomeTransplantation and Cellular Therapy, 1999
- Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.Journal of Clinical Oncology, 1993